share_log

Yifeng Pharmacy Chain (SHSE:603939) Sheds 4.7% This Week, as Yearly Returns Fall More in Line With Earnings Growth

Yifeng Pharmacy Chain (SHSE:603939) Sheds 4.7% This Week, as Yearly Returns Fall More in Line With Earnings Growth

益丰药房(上证:603939)本周下跌4.7%,年度回报更符合创业板增长。
Simply Wall St ·  06/10 18:56

Generally speaking the aim of active stock picking is to find companies that provide returns that are superior to the market average. And while active stock picking involves risks (and requires diversification) it can also provide excess returns. For example, the Yifeng Pharmacy Chain Co., Ltd. (SHSE:603939) share price is up 78% in the last 5 years, clearly besting the market return of around 9.9% (ignoring dividends). However, more recent returns haven't been as impressive as that, with the stock returning just 16% in the last year, including dividends.

一般而言,积极选择股票的目的是寻找提供高于市场平均回报的公司。虽然积极选择股票存在风险(需要分散投资),但也可以提供额外的回报。例如,益丰药房股份有限公司(SHSE:603939)的股价在过去5年中上涨了78%,明显超过了市场回报率约9.9%(不考虑股息)。然而,最近的回报并不像那样令人印象深刻,包括股息在内的股票在过去一年中仅回报16%。

Since the long term performance has been good but there's been a recent pullback of 4.7%, let's check if the fundamentals match the share price.

由于长期表现良好,但最近出现了4.7%的回撤,让我们来检查一下基本面是否与股价相符。

In his essay The Superinvestors of Graham-and-Doddsville Warren Buffett described how share prices do not always rationally reflect the value of a business. One way to examine how market sentiment has changed over time is to look at the interaction between a company's share price and its earnings per share (EPS).

在他的文章《格雷厄姆和多德斯维尔超级投资者》中,沃伦·巴菲特描述了股票价格并不总是反映公司价值的合理方式。考虑市场对公司的看法如何发生变化的一个不完美但简单的方法是将每股收益(EPS)的变化与股价的变动进行比较。股票价格并不总是反映公司价值的合理方式沃伦·巴菲特曾称,股票价格并不总是合理地反映了企业的价值。检查市场情绪如何随时间变化的一种方法是查看公司股价和每股收益(EPS)之间的互动。

Over half a decade, Yifeng Pharmacy Chain managed to grow its earnings per share at 24% a year. The EPS growth is more impressive than the yearly share price gain of 12% over the same period. So one could conclude that the broader market has become more cautious towards the stock.

在半个世纪的时间里,益丰药房每股收益增长率达到24%。EPS增长比同期每股股价的涨幅12%更为引人注目。因此,可以得出结论,整个市场对该股更加谨慎。

You can see below how EPS has changed over time (discover the exact values by clicking on the image).

下面可以看到每股收益随时间的变化情况(通过点击图像来查看确切数值)。

earnings-per-share-growth
SHSE:603939 Earnings Per Share Growth June 10th 2024
SHSE:603939每股收益增长2024年6月10日

We know that Yifeng Pharmacy Chain has improved its bottom line lately, but is it going to grow revenue? If you're interested, you could check this free report showing consensus revenue forecasts.

我们知道,益丰药房的净利润有所提高,但它是否会增长营业收入呢?如果您感兴趣,可以查看这份显示共识收入预测的免费报告。

What About Dividends?

那么分红怎么样呢?

As well as measuring the share price return, investors should also consider the total shareholder return (TSR). The TSR incorporates the value of any spin-offs or discounted capital raisings, along with any dividends, based on the assumption that the dividends are reinvested. Arguably, the TSR gives a more comprehensive picture of the return generated by a stock. We note that for Yifeng Pharmacy Chain the TSR over the last 5 years was 84%, which is better than the share price return mentioned above. And there's no prize for guessing that the dividend payments largely explain the divergence!

除了衡量股价回报外,投资者还应考虑总股东回报(TSR)。TSR包括任何分拆或折价融资的价值,以及假设股息被再投资的任何股息。可以说,TSR给出了一种更全面的股票回报图景。我们注意到,对于益丰药房而言,过去5年的TSR为84%,这比上面提到的股价回报要好。而且,毫无疑问,股息支付在很大程度上解释了这种差异!

A Different Perspective

不同的观点

We're pleased to report that Yifeng Pharmacy Chain shareholders have received a total shareholder return of 16% over one year. Of course, that includes the dividend. That's better than the annualised return of 13% over half a decade, implying that the company is doing better recently. Someone with an optimistic perspective could view the recent improvement in TSR as indicating that the business itself is getting better with time. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. Case in point: We've spotted 1 warning sign for Yifeng Pharmacy Chain you should be aware of.

我们很高兴地报告,益丰药房股东在过去一年中获得了总股东回报16%。当然,这包括股息。这比半个世纪以来的年化回报率13%更好,这意味着近期公司的表现更好。一个乐观的观点是,TSR的最近改善表明公司本身正在逐渐变得更好。当然可以考虑市场状况对股价的不同影响,但有更重要的因素。例如:我们发现了益丰药房的1个警告标志,您应该注意。

Of course Yifeng Pharmacy Chain may not be the best stock to buy. So you may wish to see this free collection of growth stocks.

当然,益丰药房可能不是最好的股票购买选择。因此,您可能希望查看这些增长股的免费收藏。

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Chinese exchanges.

请注意,本文引用的市场回报反映了目前在中国交易所上市的股票的市场加权平均回报。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对本文有反馈?关于内容有所顾虑?直接和我们联系。或者,发送电子邮件至editorial-team (at) simplywallst.com。
这篇文章是Simply Wall St的一般性文章。我们根据历史数据和分析师预测提供评论,只使用公正的方法论,我们的文章并不意味着提供任何金融建议。文章不构成买卖任何股票的建议,也不考虑您的目标或您的财务状况。我们的目标是带给您基本数据驱动的长期关注分析。请注意,我们的分析可能不考虑最新的价格敏感公司公告或定性材料。Simply Wall St没有任何股票头寸。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发